Bentham Science Logo

Contents

Cardiovascular & Hematological Disorders-Drug Targets , Volume 9 - Number 1

Promising Therapies in Sickle Cell Disease

, 9(1): 1 - 8

Radha Raghupathy and Henny H. Billett


DOI: 10.2174/187152909787581354




Von Willebrand Factor: Drug and Drug Target

, 9(1): 9 - 20

Simon F. De Meyer, Bauke De Maeyer, Hans Deckmyn and Karen Vanhoorelbeke


DOI: 10.2174/187152909787581327




Resistance to Imatinib in Chronic Myeloid Leukemia and Therapeutic Approaches to Circumvent the Problem

, 9(1): 21 - 28

Massimo Breccia and Giuliana Alimena


DOI: 10.2174/187152909787581363




Electrocardiographic Abnormalities in Thalassemia Patients with Heart Failure

, 9(1): 29 - 35

Luigi Mancuso, Andrea Mancuso, Elvira Bevacqua and Paolo Rigano


DOI: 10.2174/187152909787581345




Thrombotic Microangiopathies: Towards a Pathophysiology-Based Classification

, 9(1): 36 - 50

Paul Coppo and Agnes Veyradier


DOI: 10.2174/187152909787581318




Chromatin Structure and Epigenetics of Tumour Cells: A Review

, 9(1): 51 - 61

Eva Bartova, Jana Krejci, Roman Hajek, Andrea Harnicarova and Stanislav Kozubek


DOI: 10.2174/187152909787581336




Antiproliferative and Proapoptotic Effects of Proteasome Inhibitors and their Combination with Histone Deacetylase Inhibitors on Leukemia Cells

, 9(1): 62 - 77

Ota Fuchs, Dana Provaznikova, Iuri Marinov, Katerina Kuzelova and Ivan Spicka


DOI: 10.2174/187152909787581372




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science